Home › Attention Deficit Hyperactivity Disorder › California › Irvine
Attention Deficit Hyperactivity Disorder clinical trials in Irvine, CA
4 studies for Attention Deficit Hyperactivity Disorder are looking for participants at sites in and around Irvine (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
RecruitingPhase 3
- Clinical Research Site, Irvine
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
RecruitingPhase 3
- Clinical Research Site, Irvine
AWARE: Management of ADHD in Autism Spectrum Disorder
RecruitingPhase 4
- University of California, Irvine, Irvine
Digital Health Intervention for Children With ADHD
Recruiting
- The Craig School, Irvine
About Attention Deficit Hyperactivity Disorder
Attention deficit hyperactive disorder (ADHD) is a neurodevelopmental disorder. Its main symptoms are inattention, hyperactivity, and impulsivity. Learn more.
More about Attention Deficit Hyperactivity Disorder on MedlinePlus
Attention Deficit Hyperactivity Disorder trials in other cities
- Boston, MA10 studies
- Cincinnati, OH8 studies
- Washington, DC7 studies
- Austin, TX7 studies
- Philadelphia, PA6 studies
- Las Vegas, NV6 studies
- Pittsburgh, PA5 studies
- Portland, OR5 studies
- Orlando, FL5 studies
- Atlanta, GA5 studies
- Jacksonville, FL5 studies
- Baltimore, MD4 studies
Other studies in Irvine
- Non-Small Cell Lung Cancer30 studies
- Breast Cancer23 studies
- Cancer (all types)18 studies
- Metastatic Cancer16 studies
- Lung Cancer15 studies
- Ovarian Cancer14 studies
- Prostate Cancer14 studies
- Multiple Myeloma14 studies
- Alzheimer's Disease12 studies
- Head and Neck Squamous Cell Carcinoma11 studies
- Bladder Cancer11 studies
- Colorectal Cancer11 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.